Ulex europaeus
Ulex europaeus · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Ulex europaeus, commonly known as common gorse, is a hardy evergreen shrub characterized by its dense, thorny structure. Beyond its physical presence, this plant possesses a complex biochemical profile that includes androgenic and analgesic properties. However, certain components of the species are noted for their allergenic potential and their use as an abortifacient. In medicinal contexts, researchers have also studied its ability to induce a hypoglycemic effect. Understanding these diverse biological activities is essential for evaluating the plant's impact on human health.
- Synonyms
- Genista Europaea
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Ulex europaeus is a versatile plant known by a diverse array of regional names across different cultures. In certain areas, it is referred to by the traditional names Aiteann gallda or simply Aith. Moving into different linguistic contexts, the species is also identified as Almindelig tornblad. Other unique monikers include the descriptive Djiniesse ås spenes and the term Doornestruke. These various common names highlight the widespread presence and botanical recognition of this species throughout various landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Ulex europaeus is a prominent species widely recognized in botanical studies for its distinct characteristics. In various taxonomic records, this plant is also identified by its synonym, Genista europaea. Understanding these nomenclatural connections is essential for researchers tracking the distribution of the species. While the names may differ depending on the classification system used, they both refer to the same biological entity. Recognizing these relationships ensures clarity and accuracy within scientific literature.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Ulex europaeus is a fascinating botanical specimen belonging to the kingdom Plantae. Within this vast biological group, it is classified under the class Equisetopsida. It falls specifically under the order Fabales, showcasing its unique evolutionary lineage. Further narrowing its identity, the plant is a member of the diverse family Fabaceae. Finally, it is categorized under the genus Ulex, which defines its distinct morphological characteristics.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Ulex |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Ulex europaeus displays a widespread distribution across several distinct regions within and around the African continent. In East Tropical Africa, the species can be found specifically within the landscapes of Tanzania. Its presence extends significantly into the Macaronesian islands, where it inhabits the Azores, Madeira, and the Canary Islands. Furthermore, this plant reaches into the remote Middle Atlantic Ocean, establishing itself on Ascension Island. These diverse locations highlight the plant's ability to thrive in varied island and continental environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Ulex europaeus typically manifests as a sturdy, self-supporting shrub. This resilient plant exhibits a versatile growth form that allows it to thrive in various environments. Depending on its specific conditions, its height can range from a minimum of 0.5 meters to a maximum of 3 meters. In many established instances, the species reaches a more consistent minimum height of approximately 1.1165 meters. Such structural diversity ensures that the plant remains a prominent feature in its natural landscape.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Ulex europaeus agglutinin I (UEA1) plays a critical role in treating blood glucose levels by enhancing the oral absorption of insulin. When incorporated into modified liposomes, this substance effectively demonstrates a significant hypoglycemic effect in both healthy and diabetic mice. The research indicates that UEA1 modified liposomes can reduce blood glucose levels by up to 90% in healthy subjects and 86% in diabetic subjects over a twelve-hour period. This therapeutic action is achieved through a specific-site combination on the M cell membrane within the gastrointestinal tract. Consequently, the use of UEA1 facilitates the management of glucose by ensuring more efficient insulin delivery.